James Haddleton
Director/Board Member at Iethico Ltd.
Profile
James Haddleton is currently a Non-Executive Director at Iethico Ltd.
He previously worked as a Secretary at Clinigen Ltd.
James Haddleton active positions
Companies | Position | Start |
---|---|---|
Iethico Ltd.
Iethico Ltd. Information Technology ServicesTechnology Services Iethico Ltd. is a British company that aims to reduce the impact of medicine shortages and provide faster access to medicine. The company is based in Coventry, UK. The company links pharmacists to suppliers to bridge the gap between medicine access and supply. The company delivers insights to minimize medicine shortage impact through AI. The company was founded in 2021 by Renee Kalia, Claudio Zurzica. Debra Ainge has been the CEO of the company since 2020. | Director/Board Member | 2021-12-31 |
Former positions of James Haddleton
Companies | Position | End |
---|---|---|
CLINIGEN GROUP PLC | Corporate Secretary | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Clinigen Ltd.
Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom. | Commercial Services |
Iethico Ltd.
Iethico Ltd. Information Technology ServicesTechnology Services Iethico Ltd. is a British company that aims to reduce the impact of medicine shortages and provide faster access to medicine. The company is based in Coventry, UK. The company links pharmacists to suppliers to bridge the gap between medicine access and supply. The company delivers insights to minimize medicine shortage impact through AI. The company was founded in 2021 by Renee Kalia, Claudio Zurzica. Debra Ainge has been the CEO of the company since 2020. | Technology Services |
- Stock Market
- Insiders
- James Haddleton